OTCMKTS:PTNT Palatin Technologies (PTNT) Stock Price, News & Analysis $24.06 -0.36 (-1.47%) As of 10/16/2026 04:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartInsider TradesNews and TrendsSEC Filings About Palatin Technologies Stock (OTCMKTS:PTNT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Palatin Technologies alerts:Sign Up Key Stats Today's Range$24.06▼$24.0650-Day Range$23.83▼$25.2252-Week Range$23.83▼$28.06Volume10 shsAverage Volume759 shsMarket Capitalization$962.40 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Palatin Technologies, Inc. is a biopharmaceutical company focused on developing medicines that target melanocortin receptors, a group of receptors involved in regulating appetite, sexual function, inflammation, and other physiological processes. The company’s research programs are intended to address conditions in areas such as obesity, sexual dysfunction, inflammatory disease, and related disorders. Palatin’s best-known product is Vyleesi (bremelanotide), a melanocortin receptor agonist approved by the U.S. Food and Drug Administration in 2019 for the treatment of acquired, generalized hypoactive sexual desire disorder in premenopausal women. Palatin developed the therapy and pursued commercialization through licensing arrangements with pharmaceutical partners. Founded in the 1980s and headquartered in Cranbury, New Jersey, Palatin has historically advanced its drug candidates through internal research, clinical development, and collaborations with outside pharmaceutical companies. Its programs have primarily focused on the potential of melanocortin-based therapies in the United States and other international markets.AI Generated. May Contain Errors. Read More Receive PTNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Palatin Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PTNT Stock News HeadlinesPalatin Technologies (OTCMKTS:PTNT) Stock Breaks Above 200 Day Moving Average - Should You Sell?October 16 at 2:41 AM | americanbankingnews.comPalatin Technologies (OTCMKTS:PTNT) Share Price Breaks Above 200 Day Moving Average - Here's What HappenedOctober 8, 2026 | americanbankingnews.comMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005. Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade. | The Oxford Club (Ad)Palatin Targets the Next Generation of Rare Obesity Therapies After MC4R Validation (NASDAQ: PTN)September 28, 2026 | markets.businessinsider.comWhat the $10B Crinetics Deal & $2.9B Soleno Acquisition Might Say About Palatin’s Rare-Obesity OpportunityJuly 22, 2026 | markets.businessinsider.comPalatin Technologies Is Pursuing the Next Generation of MC4R. Rhythm Just Reinforced Why That MattersJune 18, 2026 | theglobeandmail.comPalatin Technologies Voluntarily Transfers Stock Listing to NasdaqMay 19, 2026 | theglobeandmail.comPalatin Technologies, Inc.: Palatin to Begin Trading on Nasdaq Stock ExchangeMay 19, 2026 | finanznachrichten.deSee More Headlines PTNT Stock Analysis - Frequently Asked Questions How have PTNT shares performed this year? Palatin Technologies' stock was trading at $5.60 at the start of the year. Since then, PTNT shares have increased by 329.6% and is now trading at $24.06. How were Palatin Technologies' earnings last quarter? Palatin Technologies, Inc. (OTCMKTS:PTNT) issued its earnings results on Wednesday, May, 15th. The biopharmaceutical company reported ($26.50) earnings per share for the quarter, missing analysts' consensus estimates of ($25.00) by $1.50. Read the conference call transcript. When did Palatin Technologies' stock split? Shares of Palatin Technologies reverse split on the morning of Tuesday, August 12th 2025.The 1-50 reverse split was announced on Tuesday, August 12th 2025. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, August 12th 2025. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. How do I buy shares of Palatin Technologies? Shares of PTNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Palatin Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Palatin Technologies investors own include NVIDIA (NVDA), Micron Technology (MU), NIO (NIO), Alibaba Group (BABA), Tesla (TSLA), Advanced Micro Devices (AMD) and Sorrento Therapeutics (SRNE). Company Calendar Last Earnings5/15/2024Today10/16/2026Fiscal Year End6/30/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolOTCMKTS:PTNT Previous SymbolPINK:PTNT CIK911216 Webwww.palatin.com Phone(609) 495-2200Fax609-495-2202Employees30Year FoundedN/AProfitability EPS (Trailing Twelve Months)($60.00) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$29.74 million Net MarginsN/A Pretax Margin-1,590.66% Return on EquityN/A Return on Assets-365.57% Debt Debt-to-Equity RatioN/A Current Ratio0.38 Quick Ratio0.38 Sales & Book Value Annual Sales$4.49 million Price / Sales0.21 Cash FlowN/A Price / Cash FlowN/A Book Value($0.25) per share Price / Book-96.24Miscellaneous Outstanding Shares40,000Free Float18,160,000Market Cap$962.40 thousand OptionableNot Optionable Beta-1.56 Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (OTCMKTS:PTNT) was last updated on 10/16/2026 by MarketBeat.com Staff. From Our PartnersTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billi...Banyan Hill Publishing | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Palatin Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Palatin Technologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
